The U.S. Food and Drug Administration’s Transparency Task Force today released 21 draft proposals for public comment on public disclosure policies aimed at helping consumers, stakeholders, and others understand how the agency operates and makes decisions. The Transparency Task Force will review the comments and decide which proposals to recommend for implementation.

The proposals, to be published in the May 21, 2010, Federal Register, are part of the second phase of the FDA’s Transparency Initiative launched last summer by FDA Commissioner Margaret A. Hamburg, M.D.

(More)